146887-20-9

Basic information

• Product Name: 1,3,5-Triazin-2-amine, 4,6-dichloro-N-[4-(1,1-dimethylethyl)phenyl]-
• CAS NO: 146887-20-9
• Molecular Formula: C13H14Cl2N4
• Molecular Weight: 297.187
• Mol File: 146887-20-9.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: 1,3,5-Triazin-2-amine, 4,6-dichloro-N-[4-(1,1-dimethylethyl)phenyl]-(CAS DataBase Reference)
• NIST Chemistry Reference: 1,3,5-Triazin-2-amine, 4,6-dichloro-N-[4-(1,1-dimethylethyl)phenyl]-(146887-20-9)
• EPA Substance Registry System: 1,3,5-Triazin-2-amine, 4,6-dichloro-N-[4-(1,1-dimethylethyl)phenyl]-(146887-20-9)

Safety Data

• Hazardous Substances Data: 146887-20-9(Hazardous Substances Data)

Usage

Explanation

The molecular formula represents the number of atoms of each element present in a molecule. In this case, the compound has 12 carbon (C), 11 hydrogen (H), 2 chlorine (Cl), and 5 nitrogen (N) atoms.

Explanation

Triazinamine is a class of organic compounds containing a triazine ring with an amine group. The given compound is a derivative of this class, meaning it has a similar structure with some modifications.

Explanation

The substituent is a part of the compound that replaces a hydrogen atom in the parent structure. In this case, the substituent contains two chlorine atoms and a phenyl group with a tert-butyl group (1,1-dimethylethyl) attached to it.

Explanation

The compound has a triazine ring, which is a six-membered ring consisting of three carbon atoms and three nitrogen atoms.

Explanation

Due to its structure and properties, the compound may have biological activity and can be used as a building block in the synthesis of other organic compounds, making it relevant in the fields of medicinal chemistry and pharmaceuticals.

Explanation

The compound's structure suggests that it may have biological activity, which could be useful in the development of new drugs or therapies.

Explanation

The compound's structure allows it to be used as a starting point for the synthesis of other organic compounds, making it a valuable tool in the development of new chemical entities.

Class

Triazinamine derivative

Substituent

4,6-dichloro-N-[4-(1,1-dimethylethyl)phenyl]-

Structure

Contains a triazine ring

Potential applications

Medicinal chemistry and pharmaceuticals

Biological activity

Possible

Synthesis

Can be used as a building block

Upstream product

• 108-77-0 1,3,5-trichloro-2,4,6-triazine 
• 769-92-6 4-tert-Butylaniline 

Downstream Products

• 361523-39-9 4-amino-6-chloro-2-(4'-tert-butylanilino)-1,3,5-triazine 
• 155786-14-4 carbamic acid <<5-<<<4-amino-6-<<4-(1,1-dimethylethyl)phenyl>amino>-1,3,5-triazin-2-yl>amino>methyl>-2,4-bis(1-methylethyl)phenyl>methyl>-1,1-dimethylethyl ester 
• 1005346-55-3 2-chloro-4-(4-tertbutylphenylamino)-6-(4-iodophenylamino)-1,3,5-triazine 
• 361523-40-2 4-chloro-2-(4'-tert-butylanilino)-6-dibutylamino-1,3,5-triazine 
• 361523-47-9 1,3-N,N'-bis[4-chloro-6-(tert-butylamino)-1,3,5-triazin-2-yl]xylene diamine 
• 155786-13-3 (5-{[4-(4-tert-Butyl-phenylamino)-6-chloro-[1,3,5]triazin-2-ylamino]-methyl}-2,4-diisopropyl-benzyl)-carbamic acid tert-butyl ester 
• 1005346-57-5 2-amino-4-(4-tertbutylphenylamino)-6-[4-(trimethylsilylethynyl)phenylamino]-1,3,5-triazine 
• 1005346-56-4 2-amino-4-(4-tertbutylphenylamino)-6-(4-iodophenylamino)-1,3,5-triazine 
• 1005346-58-6 2-amino-4-(4-tertbutylphenylamino)-6-(4-ethynylphenylamino)-1,3,5-triazine 

Relevant articles and documents

Discovery of Mycobacterium tuberculosis Rv3364c-Derived Small Molecules as Potential Therapeutic Agents to Target SNX9 for Sepsis

The serine protease inhibitor Rv3364c of Mycobacterium tuberculosis (MTB) is highly expressed in cells during MTB exposure. In this study, we showed that the 12WLVSKF17 motif of Rv3364c interacts with the BAR domain of SNX9 and inhibits endosome trafficki

SUBSTITUTED PYRIDIN-2-YLAMINE ANALOGUES

Substituted pyridin-2-ylamine analogues are provided, of the formula: wherein variables are as described herein. Such compounds are ligands that may be used to modulate specific receptor activity in vivo or in vitro, and are particularly useful in the tre

Self-assembly through hydrogen Bonding: Peripheral crowding - A new strategy for the preparation of stable supramolecular aggregates based on parallel, connected CA3·M3 rosettes

The self-assembly of two new types of stable hydrogen-bonded supramolecular aggregates - bisrosettes - that are based on parallel, connected CA3·M3 rosettes is reported. The minimization of intermolecular steric hindrance - periphera